All Pathways
NeurologyDiagnostic

TIA Workup and Secondary Stroke Prevention

TIA Workup and Secondary Stroke Prevention: Suspected TIA → Urgent Evaluation → Calculate ABCD2 Score → Brain and Vascular Imaging → Cardiac Evaluation.

Interactive Decision Tree

Mini Map

Algorithm Steps

  1. Start

    Suspected TIA

    Transient focal neurological deficit, resolved

    1. Action

      Urgent Evaluation

      Complete workup within 24-48 hours

      • Risk of stroke highest in first 48h
      • ED observation unit or TIA clinic
      • ESO recommends 24h workup
      • AHA allows up to 48h
      1. Action

        Calculate ABCD2 Score

        Risk stratification tool

        • A: Age ≥60 (+1)
        • B: BP ≥140/90 (+1)
        • C: Clinical features: unilateral weakness (+2), speech impairment (+1)
        • D: Duration ≥60 min (+2) or 10-59 min (+1)
        • D: Diabetes (+1)
        • Score 0-3: low, 4-5: moderate, 6-7: high risk
        1. Action

          Brain and Vascular Imaging

          MRI preferred over CT

          • MRI with DWI (detects 30-50% have infarct)
          • MRA or CTA of head and neck
          • Carotid ultrasound if MRA/CTA unavailable
          • CT/CTA if MRI contraindicated
          1. Action

            Cardiac Evaluation

            Search for cardioembolic source

            • ECG (look for AFib)
            • Echocardiogram (TTE, consider TEE)
            • Cardiac monitoring ≥24h
            • Extended monitoring if cryptogenic (30 days)
            1. Decision

              Determine Etiology

              TOAST classification

              • Large artery atherosclerosis
              • Cardioembolism (AFib, PFO, etc.)
              • Small vessel disease
              • Other determined cause
              • Cryptogenic
              1. Action

                Atrial Fibrillation

                Anticoagulation indicated

                • DOAC preferred over warfarin
                • Calculate CHA₂DS₂-VASc
                • Assess bleeding risk (HAS-BLED)
                • No need for concurrent antiplatelet usually
                1. Action

                  Risk Factor Management

                  Long-term secondary prevention

                  • BP target <130/80 mmHg
                  • High-intensity statin (LDL <70 mg/dL)
                  • Glycemic control (HbA1c <7%)
                  • Smoking cessation
                  • Mediterranean diet, exercise
                  1. Outcome

                    Secondary Prevention Initiated

                    Follow-up and monitoring

                    • Neurology follow-up in 1-2 weeks
                    • Primary care for risk factor management
                    • Stroke education, warning signs
                    • Driving restrictions per local laws
              2. Decision

                Carotid Stenosis?

                Check for symptomatic stenosis

                • Ipsilateral to symptoms
                • ≥50% NASCET criteria = significant
                • ≥70% strongly consider intervention
                1. Action

                  Carotid Revascularization

                  CEA or CAS if indicated

                  • CEA within 2 weeks if symptomatic 70-99%
                  • Consider for 50-69% based on risk factors
                  • CAS alternative if high surgical risk
                  • Dual antiplatelet before and after CAS
                2. Action

                  Non-Cardioembolic TIA

                  Antiplatelet therapy

                  • DAPT (aspirin + clopidogrel) for 21-30 days
                  • Start within 24h of symptom onset
                  • Then single antiplatelet long-term
                  • High-intensity statin (LDL target <70)
                  1. Action

                    DAPT Protocol (POINT/CHANCE)

                    Short-term dual antiplatelet

                    • Aspirin 325 mg load + clopidogrel 300 mg load
                    • Then ASA 81 mg + clopidogrel 75 mg daily
                    • Duration: 21 days (CHANCE) to 90 days (POINT)
                    • Most benefit in first 21 days
                    • After DAPT: single agent (clopidogrel or ASA)
                    1. Action

                      Intracranial Stenosis

                      If 70-99% symptomatic stenosis

                      • DAPT (ASA + clopidogrel) up to 90 days
                      • Aggressive medical management preferred
                      • Stenting NOT recommended (SAMMPRIS)
                      • Consider in failure of medical therapy only
          2. Action

            Laboratory Studies

            Standard workup

            • Fasting lipid panel (target LDL <70)
            • HbA1c, fasting glucose
            • CBC, BMP, coagulation studies
            • Consider hypercoagulability workup if young

Guideline Source

2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack - AHA/ASA

Clinical Safety Information

Clinical Decision Support — Not a Substitute for Clinical Judgment

Individual patient factors may require deviation from these recommendations.

Known Limitations

  • Does not cover pediatric stroke/TIA
  • Assumes access to MRI/MRA
  • Anticoagulation decisions require individual bleeding risk assessment
  • DAPT duration varies by specific scenario

Contraindicated Populations

pediatric

Applicable Regions

USEUglobal

EU: ESO guidelines similar but 24h workup window preferred

US: AHA/ASA 2021 guidelines followed

Version 1Next review: 2027-01-01

Frequently Asked Questions

What is the TIA Workup and Secondary Stroke Prevention?

The TIA Workup and Secondary Stroke Prevention is a diagnostic clinical algorithm for Neurology. It provides a structured decision tree to guide clinical decision-making, based on 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack - AHA/ASA.

What guideline is the TIA Workup and Secondary Stroke Prevention based on?

This algorithm is based on 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack - AHA/ASA (DOI: 10.1161/STR.0000000000000375).

What are the limitations of the TIA Workup and Secondary Stroke Prevention?

Known limitations include: Does not cover pediatric stroke/TIA; Assumes access to MRI/MRA; Anticoagulation decisions require individual bleeding risk assessment; DAPT duration varies by specific scenario. Individual patient factors may require deviation from these recommendations.

Get AI-Powered Analysis Alongside This Algorithm

In AttendMe.ai, the TIA Workup and Secondary Stroke Prevention appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.

Try AttendMe Free